Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scholar Rock
Biotech
Phase 3 Scholar Rock trial hits SMA goal, sending stock up 327%
Investors went wild despite the higher dose falling short of the targeted efficacy and Scholar Rock making no mention of a key secondary goal.
Nick Paul Taylor
Oct 7, 2024 8:45am
Exscientia fires CEO—Chutes & Ladders
Feb 16, 2024 9:30am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
Maxwell Biosciences taps 3 leaders—Chutes & Ladders
Sep 23, 2022 9:30am
Celgene, Acceleron alum Backstrom tapped to lead Scholar Rock
Sep 20, 2022 11:20am
Scholar Rock bags $205M as 24-month data point to SMA durability
Jun 17, 2022 10:34am
